The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment-Reference-Cited by-同舟云学术

The neuroprotective agent SR 57746A abrogates experimental autoimmune encephalomyelitis and impairs associated blood-brain barrier disruption: Implications for multiple sclerosis treatment

Published:1999-10-26 Issue:22 Volume:96 Page:12855-12859
ISSN:0027-8424
Container-title:Proceedings of the National Academy of Sciences
language:en
Short-container-title:Proceedings of the National Academy of Sciences

Author:

Bourrie B.,Bribes E.,Esclangon M.,Garcia L.,Marchand J.,Thomas C.,Maffrand J.-P.,Casellas P.

Publisher

Proceedings of the National Academy of Sciences

Subject

Multidisciplinary

Reference38 articles.

1. Cytokine mRNA levels in mononuclear blood cells from patients with multiple sclerosis

2. Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions.

3. The adhesion molecule and cytokine profile of multiple sclerosis lesions

4. Hypothesis: A role for tumor necrosis factor in immune-mediated demyelination and its relevance to multiple sclerosis

Cited by 17 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Activated microglia drive demyelination via CSF1R signaling;Glia;2021-02-23

2. Axonal and Myelin Neuroprotection by the Peptoid BN201 in Brain Inflammation;Neurotherapeutics;2019-02-27

3. Microglia are necessary for toxin-mediated demyelination and activation of microglia is sufficient to induce demyelination;2018-12-19

4. Pharmacological Induction of Transforming Growth Factor-Beta1 in Rat Models Enhances Radiation Injury in the Intestine and the Heart;PLoS ONE;2013-07-25

5. Role of ethanolamine phosphate in the hippocampus of rats with acute experimental autoimmune encephalomyelitis;Neurochemistry International;2011-01